Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13:42 | Alpha Tau Medical stock holds Buy rating at H.C. Wainwright after license win | 1 | Investing.com | ||
Di | Alpha Tau Medical Ltd.: Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness | 2 | GlobeNewswire (USA) | ||
Di | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
02.09. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial | 3 | GlobeNewswire (USA) | ||
27.08. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
11.08. | Alpha Tau Medical Ltd.: Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update | 247 | GlobeNewswire (Europe) | - FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S. clinical... ► Artikel lesen | |
23.06. | Alpha Tau files to sell 3.46M ordinary shares by selling shareholders | 3 | Seeking Alpha | ||
17.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
28.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
19.05. | Alpha Tau Medical GAAP EPS of -$0.11 | 1 | Seeking Alpha | ||
19.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update | 275 | GlobeNewswire (Europe) | - Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive... ► Artikel lesen | |
19.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
12.05. | Alpha Tau Medical ernennt neues Vorstandsmitglied | 5 | Investing.com Deutsch | ||
12.05. | Alpha Tau Medical Ltd.: Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors | 1 | GlobeNewswire (USA) | ||
06.05. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
28.04. | Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical | 9 | Seeking Alpha | ||
28.04. | Oramed investiert 36,9 Millionen US-Dollar in Alpha Tau Krebstherapie | 30 | Investing.com Deutsch | ||
28.04. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
28.04. | Alpha Tau Medical Ltd.: Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals | 7 | GlobeNewswire (USA) | ||
28.04. | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical | 544 | PR Newswire | Oramed leverages its strategic capital markets expertise to support Alpha Tau's breakthrough cancer therapy technology
Accelerating multiple late-stage cancer therapies... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 48,970 | +1,43 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius auf "Overweight" mit einem Kursziel von 49,10 Euro belassen. Die vom Bundeskabinett beschlossenen pauschalen Vergütungen... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 46,740 | -0,91 % | Branicks, CTS Eventim, FMC, Norma Group, Puma, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 32,940 | 0,00 % | Jefferies hebt Kursziel für BrightSpring Health wegen starker Fundamentaldaten auf 36 US-Dollar an | ||
SIEMENS HEALTHINEERS | 49,190 | -0,30 % | PRESSESPIEGEL/Unternehmen: KUNUNU, DEUTSCHE BANK, SIEMENS HEALTHINEERS, WIRECARD, SUPER 8 | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
KUNUNU - Die Arbeitgeber-Bewertungsplattform Kununu steht vor einem Eigentümerwechsel.... ► Artikel lesen | |
PROGYNY | 19,170 | 0,00 % | Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause | Global employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health... ► Artikel lesen | |
AVEANNA HEALTHCARE | 9,470 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Preliminary Third Quarter Financial Results | ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
GERRESHEIMER | 27,700 | 0,00 % | Bitcoin Group, Continental, Energiekontor, Gerresheimer, HelloFresh, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
GOODRX | 3,770 | 0,00 % | GoodRx Stock Could Get a Major Trump Boost. Should You Buy It Here? | ||
UNITEDHEALTH | 306,60 | -1,59 % | UnitedHealth: Zu viel Optimismus? | Die Aktie des größten US-amerikanischen Krankenversicherers hat sich in den zurückliegenden Wochen zwar deutlich von den Mehrjahrestiefs nach oben lösen können. Allerdings notiert der Titel immer noch... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 17,405 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | ||
PROCEPT BIOROBOTICS | 35,080 | 0,00 % | Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock | ||
CARL ZEISS MEDITEC | 47,060 | -0,63 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 35,10 Euro belassen. Anchal Verma sieht in einer am Freitag vorliegenden... ► Artikel lesen | |
GENEDX | 120,95 | 0,00 % | 4 Analysts Assess GeneDx Holdings: What You Need To Know | ||
AIRSCULPT TECHNOLOGIES | 10,220 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance | MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
PICARD MEDICAL | 13,060 | 0,00 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2025 Financial Results | Strong commercial momentum driven by higher product sales - Total revenue and $19.5 million IPO proceeds support expansion and innovation in artificial heart technology - TUSCON, Ariz., Sept. 15,... ► Artikel lesen |